-
In section: UMass Chan News
In subsection: News Archives
diseases: Hemant Khanna, PhD
In search of . . . treatments for retinal diseases: Hemant Khanna, PhD
Hemant Khanna, retinal degnerative diseases, CEP290, RPGR, RP2
On Tuesdays, the Daily Voice features a first-person narrative from a researcher explaining the science behind a recent grant, and the inspiration or impetus behind becoming a scientist at UMass Medical School. If you know of a researcher you’d like to see profiled, send an email to UMassChanCommunications@umassmed.edu. Name: Hemant Khanna
Last modified: Dec 20, 2013
-
In section: UMass Chan News
In subsection: News Archives
Research by Hemant Khanna and the Horae Gene Therapy Center at UMass Medical School explores gene therapy for the most common form of Leber congenital amaurosis.
Last modified: Aug 25, 2017
-
In section: UMass Chan News
In subsection: News Archives
Hemant ... Hemant Khanna, an ophthalmology and visual sciences researcher, writes about a recent report in which scientists have found a new approach to target retinoblastoma using cancer-killing viruses.
Last modified: Feb 04, 2019
-
In section: UMass Chan News
In subsection: News Archives
In a piece originally published on The Conversation, Hemant Khanna, PhD, comments on recent studies that use CRISPR to treat diseases that cause blindness and explains why the eye is an ideal organ for testing new therapeutic approaches.
Last modified: Jun 25, 2020
-
In section: UMass Chan News
In subsection: News Archives
licensed the exclusive global rights to develop and commercialize novel adeno-associated virus gene therapy product candidates for the treatment of Leber congenital amaurosis type 10 to IVERIC bio, Inc. The product was developed from research by Hemant Khanna, PhD, in collaboration with Guangping Gao, PhD.
Last modified: Sep 11, 2019
-
In section: UMass Chan News
In subsection: News Archives
collaboration with UMass Medical School and its Horae Gene Therapy Center focused on applying novel gene therapy technology to discover and develop next-generation therapies for the treatment of ocular diseases.
Guangping Gao, PhD Hemant Khanna, PhD Ophthotech Corporation has initiated a research collaboration with UMass Medical School and its Horae Gene Therapy Center focused on applying novel gene therapy technology to discover and develop next-generation therapies for the treatment
Last modified: Feb 28, 2018
-
In section: UMass Chan News
In subsection: News Archives
UMass Chan experts: New gene therapy success holds promise for degenerative retinal diseases - UMass Medical School - Worcester
UMass Chan experts: New gene therapy success holds promise for degenerative retinal diseases
Khanna and Punzo weigh in on recent clinical trial results
Bryan Goodchild and Ellie Castano
UMass Medical School Communications
Gene therapy researchers at UMass Medical School focused on degenerative retinal diseases are calling a promising new study out of University of Oxford
Last modified: Feb 10, 2014
-
In section: UMass Chan News
In subsection: News Archives
genomics to identify oncogenes Gang Han, PhD, assistant professor of biochemistry & molecular pharmacology: Near infared emitting upconverting nanoparticles for in vivo imaging of siRNA delivery and silencing in neurodegenerative disease management Hemant Khanna, PhD, assistant professor of ophthalmology: Pathogenic mechanisms of CEP290-associated early childhood blindness disorder Leber Congenital Amaurosis Andrei Korosatelev, PhD, assistant professor of biochemistry & molecular pharmacology: Structural
Last modified: Dec 20, 2013
-
In section: UMass Chan News
In subsection: News Archives
While recent forays into gene therapy treatments for other forms of inherited retinal disease have been encouraging, the relatively large size of both the LCA10 and Stargardt genes have been a roadblock to using AAV vectors for treatment. In 2017, Hemant Khanna, PhD, then an associate professor of ophthalmology & visual sciences at UMass Chan, and now vice president of preclinical ocular research at Iveric Bio, developed a “minigene” approach to deliver a shorter version of the gene using clinically standard
Last modified: Jan 30, 2024
-
In section: UMass Chan News
In subsection: News Archives
announced the launch of an ophthalmology residency program, recently approved by the Accreditation Council for Graduate Medical Education.
Front: Shlomit Schaal, MD, PhD; Misha Faustina, MD Back: Gabriel Luna, MD; Dan Yoon, MD; Haijiang Lin, MD, PhD; Hemant Khanna, PhD; Priya Janardhana, MD; Juan Ding, OD, PhD; Justine Grier, OD; Claudio Punzo, PhD The Department of Ophthalmology & Visual Sciences at UMass Medical School has announced the launch of an ophthalmology residency program, recently approved by
Last modified: May 08, 2019